Enanta Pharmaceuticals Inc (ENTA) earnings · rev $65.3M
These earnings events as JSON? API free 100/dayEnanta Pharmaceuticals Inc (ENTA) is a biotechnology company listed on US.
This ENTA earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ENTA revenue for 2025-09-30 was $65.3M. Net income was -$81.9M. Revenue was down 3.4% from 2024-09-30 to 2025-09-30. ENTA currently screens at market cap $328.0M.
When the next ENTA 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 3.4% from 2024-09-30 to 2025-09-30. An earnings headline that ignores that move is noise.
Not investment advice. Full ENTA research stays on the stock page; the tape stays on the quote page.
ENTA earnings FAQ
What are ENTA's latest revenue and net income?
Latest cached Enanta Pharmaceuticals Inc (ENTA) revenue for Sep 30, 2025 was $65.3M. Net income was -$81.9M. Statements: https://lician.com/financials/enta
What is ENTA's latest diluted EPS?
Latest cached Enanta Pharmaceuticals Inc (ENTA) diluted EPS for Sep 30, 2025 was -$3.84.
What period does the latest ENTA earnings print cover?
The latest cached Enanta Pharmaceuticals Inc (ENTA) earnings print covers Sep 30, 2025. The prior cached period on this page is Sep 30, 2024.
How did ENTA revenue change from the prior cached period?
Cached Enanta Pharmaceuticals Inc (ENTA) revenue was down 3.4% from $67.6M (Sep 30, 2024) to $65.3M (Sep 30, 2025). Statements: https://lician.com/financials/enta
Where are ENTA earnings listed?
Cached earnings facts for Enanta Pharmaceuticals Inc (ENTA) are listed at https://lician.com/earnings/enta. Statements: https://lician.com/financials/enta
Not investment advice.